Regen Sphere was founded with a clear purpose: to rethink how advanced wound care is delivered-bringing treatment directly to patients at the point of need, powered by cutting-edge Al and bioactive technologies. Our journey began with frontline clinical experience during the COVID-19 pandemic and has since evolved into a mission supported by global patents, CE-marked technologies, and real-world trials that demonstrate both clinical efficacy and cost-saving potential.
We are excited to share how our approach can help address one of the NHS’s top spending areas-chronic wound care-while enhancing patient outcomes and supporting healthcare supporting professionals through intelligent, evidence-based tools. We believe that partnership is the path forward. We’re here not just to showcase our innovation, but to explore how we can work collaboratively with Health Innovation Wessex, Integrated Care Boards, and NHS community care teams to bring this solution to scale, starting in Hampshire, South Wales, and London. Thank you for your time, your attention, and your continued commitment to healthcare transformation.